• SENSEX 73,895.74
    315.20 (+0.43%)
  • BANKNIFTY 55,580.40
    141.90 (+0.26%)
  • ICICI Bank
    1,311.70 1,187.55(%)
  • NSE
    1,790.00 1,790.00(%)
  • SS Retail
    692.30 603.00(%)
  • PB Fintech.
    1,115.10 1,115.10(%)
  • The Bombay Burmah
    1,425.75 1,301.00(%)
  • Hero Motors
    141.85 141.85(%)
  • Whirlpool India
    959.60 1,438.30(%)
  • Cholaman.Inv.&Fn
    1,638.05 1,299.80(%)
  • Larsen & Toubro
    3,885.90 4,440.00(%)
  • Tour. Fin. Corp.
    135.55 51.20(%)
  • Kotak Mah. Bank
    399.35 345.40(%)
  • AU Small Finance
    1,021.20 1,144.65(%)
  • Infosys
    991.75 984.00(%)
  • Rainbow Child.
    1,351.50 1,008.75(%)
  • Kaveri Seed Co.
    844.00 1,139.90(%)
  • Cupid
    274.15 298.95(%)
  • Reliance Industries
    1,227.20 1,611.20(%)
  • HDFC Bank
    739.50 1,020.35(%)
  • Shanti Gold
    333.00 333.00(%)
  • Tata Consumer
    979.10 979.10(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Biocon Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 14801.0
  • ISIN : INE376G01013
382.15 -5 (-1.25%)
  • As on 26 Sep 2026 (EOD)

  • Today’s Low

    380.50

  • Today’s High

    388.70

  • Open

    387.50

  • Perv Close

    387.00

  • 52W Low

    337.05

  • 52W High

    447.15

Key Indicators

  • P/E(TTM)

    205.95

  • Mar.Cap (₹Cr.)

    62,278.76

  • Div & Yield %

    0.13

  • Book Value(₹)

    167.99

  • Debt-Equity Ratio

    -1.25

  • AGM Date

    25-Sep-2026

  • EPS

    1.85

  • P/E Ratio

    205.95

Financials Ratios

  • Debt-Equity Ratio

    0.91

  • Mar.Cap (₹Cr.)

    62,278.76

  • RONW (%)

    6.89

  • ROCE (%)

    6.35

Score Board

  • Equity (₹ in Cr.)

    814.85

  • BV (₹)

    168.00

  • Sales( ₹ in Cr.)

    2,346.40

  • NP (in Cr.)

    175.30

  • NP Var(%)

    445.0

  • Div%

    10.0

  • CPS (₹)

    1.90

  • EPS (₹)

    1.10

  • Traded Value (₹ in Lakhs)

    62,091.35

  • 52 Week High

    447.15

  • 52 Week Low

    337.05

  • Price BSE

    381.0

  • Price NSE

    382.00

  • Market Capital( in Cr.)

    62,091.35

  • P/C Ratio

    198.60

  • P/E Ratio

    354.20

  • Price Vs.BV

    1.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,346.40 2,242.60 2,127.30 1,992.90 1,738.20 2,028.40
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,346.40 2,242.60 2,127.30 1,992.90 1,738.20 2,028.40
Other Income 319.70 849.80 207.50 3,134.20 187.20 150.20
Stock Adjustments 118.70 54.60 99.10 -3.20 105.80 -36.70
Total Income 2,784.80 3,147.00 2,433.90 5,123.90 2,031.20 2,141.90
EXPENDITURE :            
Raw Materials 1,187.60 1,085.40 1,033.80 981.00 914.00 761.60
Power and Fuel Cost 215.80 192.00 215.30 279.20 231.00 186.00
Employee Cost 467.20 501.30 452.30 433.80 367.70 390.20
Other Manufacturing Expenses 165.90 150.70 155.40 127.10 130.50 147.00
Selling and Administration Expenses 193.20 172.00 135.00 112.20 106.70 128.40
Miscellaneous Expenses 224.40 20.00 -28.10 32.90 33.00 66.00
Employee Benefit Expenses 467.20 501.30 452.30 433.80 367.70 390.20
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 2,454.10 2,121.40 1,963.70 1,966.20 1,782.90 1,679.20
Operating Profit 330.70 1,025.60 470.20 3,157.70 248.30 462.70
Interest 142.40 236.90 198.80 69.60 0.40 0.40
Gross Profit 188.30 788.70 271.40 3,088.10 247.90 462.30
Depreciation 137.30 127.80 121.10 116.90 108.20 103.50
Profit Before Tax 51.00 660.90 150.30 2,971.20 139.70 358.80
Current Tax 12.00 30.60 15.10 132.70 60.70 73.50
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 1.80 21.00 15.90 -9.90 -7.10 4.80
Reported Net Profit 37.20 609.30 119.30 2,848.40 86.10 280.50
Extraordinary Items -138.10 660.11 13.41 2,861.73 2.92 3.00
Adjusted Net Profit 175.30 -50.81 105.89 -13.33 83.18 277.50
Adjustment below Net Profit -23.50 -1.30 30.70 29.40 -59.40 30.40
P & L Balance brought forward 10,468.50 9,920.50 9,950.60 7,132.80 7,106.10 6,795.20
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 66.80 60.00 180.10 60.00 0.00 0.00
P & L Balance carried down 10,415.40 10,468.50 9,920.50 9,950.60 7,132.80 7,106.10
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 10.00 10.00 10.00 30.00 10.00 0.00
Dividend Per Share(Rs) 0.50 0.50 0.50 1.50 0.50 0.00
Earnings Per Share-Unit Curr 0.23 5.07 0.99 23.72 0.72 2.34
Earnings Per Share(Adj)-Unit Curr 0.23 5.07 0.99 23.72 0.72 2.34
Book Value 166.85 96.63 90.88 90.91 67.40 65.88
Book Value(Adj)-Unit Curr 166.85 96.63 90.88 90.91 67.40 65.88

Shareholding Pattern

  • Promoter Group

    44.68%

  • Public Share Holding

    55.27%

  • Custodian

    0.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 237,211,164 14.56 237,211,164 1
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 6,288,161 6,288,161.00 6,288,161 6,288,161
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 243,499,325 14.94 243,499,325 3
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 484,581,970 29.73 484,581,970 1
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 484,581,970 29.73 484,581,970 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,698,270 0.10 1,698,270 3
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 132,682,448 8.14 132,682,448 244
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 103,807,569 6.37 103,807,569 19
Mutual Funds / UTI 252,089,847 15.47 252,089,847 39
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 23,488,458 1.44 23,488,458 45
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 513,766,592 31.53 513,766,592 350
2] Non Institution
Bodies Corporate 100,233,307 6.15 100,233,307 1,734
Clearing Members 5,068 0.00 5,068 8
Directors of their Relatives 8,727,353 0.54 6,693,924 3
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 12,905,734 0.79 12,553,224 9,985
Foreign Non Institution Other 91,967,019 5.64 91,967,019 1
Hindu Undivided Families 4,546,851 0.28 4,546,671 6,192
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 72,052,635 4.42 67,256,126 282
Individuals holding nominal share capital up to Rs. 1 lakh 95,105,222 5.84 93,710,339 374,251
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 457,077 0.03 457,077 17
Others 978,739 0.06 370,177 5
Sub Total 386,979,005 23.75 377,792,932 392,478
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 867,243 0.05 867,243 1
Total Shares held by Custodians and against which Depository Receipts have been issued 867,243 0.05 867,243 1
Grand Total ( A + B + C ) 1,629,694,135 100.00 1,620,450,943 392,833

Company Background

Biocon LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Biocon Ltd
  • BSE Code : 14801.0
  • ISIN : INE376G01013

  • Incorporation Year

    1978

  • Registered Office

    20th KM Hosur Road Hebbagodi
    Electronic City P O, Bangalore,
    Karnataka-560100

  • Telephone

    91-80-28082808

  • FAX

    91-80-28523423

  • Chairman

    Kiran Mazumdar Shaw

  • Managing Director

    Shreehas Pradeep Tambe

  • Company Secretary

    RAJESH UMAKANT SHANOY

  • Auditor

    B S R & Co LLP

  • Face Value

    5

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Biocon Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Biocon 381.00 2,666.10 2,346.40 635.00 1.61
Abbott India 26,935.80 7,217.19 6,929.05 35.45 43.78
Astrazeneca Phar 6,517.85 2,304.07 2,275.58 96.06 27.86
Glaxosmi. Pharma 2,816.85 3,932.76 3,790.20 45.00 58.17
Novartis India 1,961.40 393.10 354.33 49.53 15.94
Cipla 1,397.20 20,102.60 18,979.95 36.72 13.88
Bliss GVS Pharma 709.30 773.53 729.81 65.92 12.51
Amrutanjan Healt 506.15 520.13 502.55 27.11 24.16
Fermenta Biotec. 468.15 474.15 450.25 21.86 18.77
Guj. Themis Bio. 417.30 168.25 165.82 111.58 18.05
Ambalal Sarabhai 40.55 19.52 3.94 75.09 6.77